-
In April, the UAB Comprehensive Diabetes Center (UCDC) partnered with Live HealthSmart Alabama (LHSA) to bring free wellness screenings to UAB students.
-
The UAB Comprehensive Diabetes Center (UCDC) was invited to educate Birmingham Airport Authority employees on diabetes signs, symptoms, and prevention.
-
Department of Pediatrics Professor and Ralph Froshin Endowed Chair in Pediatric Endocrinology Ambika Ashraf, M.D., co-edited a book “Pediatric Dyslipidemia” alongside colleague Bhuvana Sunil, M.D.
-
UAB Comprehensive Diabetes Center Administrative Director Tiffany Grimes, R.N., recently completed the 15th cohort of the UAB Blaze Leadership Academy.
-
The University of Alabama at Birmingham Heersink School of Medicine and the UAB Comprehensive Diabetes Center (UCDC) are pleased to welcome Ananda Basu, M.D., and Rita Basu, M.D., as full professors into the Division of Endocrinology, Diabetes, and Metabolism.
-
June 2023 brings with it many endocrinology and diabetes conference opportunities. Notably, the Endocrine Society meeting, ENDO 2023, and the American Diabetes Association (ADA) 83rd scientific session.
-
Meet the 2022-2023 class of UAB’s flagship leadership academy for high-potential faculty and staff.
-
Over one million Americans are living with Type 1 diabetes (T1D). According to Beyond Type 1, the number of those with T1D is steadily climbing at 2.9% per year, versus the population growth of 0.8% per year.
-
In a new series, the UAB Comprehensive Diabetes Center (UCDC), a leader in the field of diabetes research, will highlight its dynamic faculty and trainees.
-
Three teams of researchers from UAB are analyzing the intergenerational transmission of obesity.
-
May 2023 brings with it many endocrinology and diabetes conference opportunities. Notably, the Immunology of Diabetes Society Congress meeting as well as the American Association of Clinical Endocrinologists (AACE) annual meeting.
-
Several UAB Comprehensive Diabetes Center (UCDC) members published a new review on obesity in the Journal of the American Heart Association.
-
The UAB Comprehensive Diabetes Center (UCDC) leadership is deeply saddened to share the loss of Nancy R. Gwaltney.
-
Continuous glucose monitors can transform one’s diabetes treatment and care. A UAB diabetes expert explains what patients should know about the devices when evaluating their diabetes care plans.
-
2023 officially marks the 15th anniversary of the UAB Comprehensive Diabetes Center (UCDC).
-
Continuous glucose monitors are “such a useful and impactful behavior modification tool” that half of his patients with Type 1 and Type 2 diabetes now use these devices, said Fernando Ovalle, M.D., director of UAB’s Multidisciplinary Comprehensive Diabetes Clinic. Learn[…]
-
From left to right: Drs. Habegger, Hunter, and KimSeveral UAB Comprehensive Diabetes Center (UCDC) members serve on various National Institutes of Health (NIH) study sections. Academic scientists who serve on study sections, as well as fellowship study sections, review grant[…]
-
In a new series, the UAB Comprehensive Diabetes Center (UCDC), a leader in the field of diabetes research, will highlight its dynamic faculty and trainees.
-
UAB Comprehensive Diabetes Center Member Amy Warriner, M.D., recently sat down with UAB MedCast podcast to talk about nutrition for diabetes.
-
The clinical trial focused on very young children, who have a more rapid loss of the pancreatic beta cells than do adolescents. The trial was constrained to a low-dose level, but showed safety and tolerability and reduced serum glucagon, a[…]
-
Many with diabetes might get overwhelmed or experience burnout. Follow these five self-care diabetes tips from the UAB Comprehensive Diabetes Center to show yourself some love this February.
-
This week, leaders from across UAB gathered to honor Stuart J. Frank, M.D., at the naming dedication of the Stuart J. Frank, M.D. Conference Room in the Boshell Diabetes Building (BDB). Hallways were lined with cherished colleagues, friends, and mentees.[…]
-
Gestational diabetes–a type of diabetes that develops during pregnancy–is on the rise. From 2000 to 2010, the percentage of pregnant women with gestational diabetes increased 56 percent, according to the CDC.
-
Using data from the REGARDS cohort, UAB researchers found the impact of certain stroke risk factors vary with age.
-
Anath Shalev, M.D., did everything she could to change treatment for Type 1 diabetes from her lab, but getting to first-in-human trials meant taking a step she had always resisted. The most surprising thing about launching a startup, though? “I[…]
-
Diabetic retinopathy is the leading cause of blindness in American adults. The source of this damage may lie in the belly — mainly a leaky small intestine. A novel treatment can possibly prevent or reverse this damage.
-
Maria Grant, M.D., FARVO, professor in the Department of Ophthalmology and Visual Sciences, and her colleagues have published a study that provides hope in the treatment of diabetic retinopathy.
-
Brian Barr, a former executive in the construction industry, is a recognized and prominent businessman in the Birmingham, AL community and beyond. He recently retired as a regional president at Brasfield and Gorrie.
-
Watching the portion and carb content of food and drinks can help prevent blood sugar spikes this New Year’s Eve.
-
This study will enroll patients to evaluate which combination of three proposed interventions — including health coaching, food delivery and remote patient monitoring — will help patients manage diabetes and also be sustainable for health systems to implement.
-
Donnie Bush, who has Type 1 diabetes, and his wife DeDee have endowed a legacy gift to the UAB Comprehensive Diabetes Center to promote cutting-edge diabetes research.
-
Eugenia Kharlampieva’s commitment to high-caliber diabetes and cancer research using polymer chemistry has earned her recognition as the 2022 Ireland Prize recipient.
-
Three UAB employees share their diabetes journey and provide healthy tips in honor of Diabetes Awareness Month.
-
Ava Michl was traversing her new collegiate world through freshman year at the University of Alabama at Birmingham when she was rocked by an unexpected Type 1 diabetes diagnosis. Up to that point in her life, Michl had no idea[…]
-
Department of Psychology Associate Professor Michael Sloane, Ph.D., grew up in the rolling countryside of Ireland, where processed foods were far from a dietary staple– everything was farm to table. His family grew all their own vegetables and fruits, raised[…]
-
The year was 1997. Department of Medicine Communications Director Carolyn Walsh was traveling on i459 when things did not feel quite right. She was fighting to stay awake at the wheel, noticing bouts of drowsiness on and off. Before she[…]
-
At their annual Innovation Awards, UAB’s Bill L. Harbert Institute for Innovation and Entrepreneurship celebrated innovators from all corners of campus for their accomplishments, inventions and ingenuity.
-
Given the rising rates of obesity and diabetes, semaglutide could be used effectively to reduce the burden of these chronic diseases.
-
Knockout of TXNIP improves diabetes-associated hyperglycemia and hyperglucagonemia.
-
Published results suggest the COVID-19 pandemic exacerbated the slow increase in pediatric Type 2 diabetes.
-
Carbohydrates are directly linked to the development of Type 2 diabetes, but a higher-carb diet is underused in research models.
-
Seven questions for Michael Sloane, Ph.D., on his seven-year quest to race on every continent.
-
UAB Heersink School of Medicine staff council representatives have officially been named for the 2022-2024 term. See who has been elected to represent you!
-
The Council on Basic Cardiovascular Sciences, known as the BCVS, is one of the largest councils at the American Heart Association, and it is one of the largest organizations in cardiovascular sciences globally, with more than 4,700 members.
-
This therapy, using sustained release of nitric oxide, may be a novel, efficient and safe way to prevent and treat multiple metabolic diseases.
-
Benefits of the blood pressure medication verapamil include delayed disease progression, lowered insulin requirements and preservation of some beta cell function.
-
Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.
-
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — was associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes.
-
These lipids may act as a biomarker for Type 1 diabetes and offer a therapeutic target to prevent the disease.
-
The drug candidate is a non-toxic small molecule that given orally effectively rescued mice from models of Type 1 and Type 2 diabetes.
